Science Explorer Back to mapMap
Institution · Mutabilis (France)

Most cited papers from Mutabilis (France)

What are the most cited papers from Mutabilis (France)?

The most cited paper from Mutabilis (France) is "Molecular diversity of spirooxindoles. Synthesis and biological activity" (Tetiana Pavlovska, Ruslan Gr. Redkin, Victoria V. Lipson et al., 2015), with 347 citations. Next come "Antivirulence as a new antibacterial approach for chemotherapy" (178) and "Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage" (131).

Showing 34 of 34 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Molecular diversity of spirooxindoles. Synthesis and biological activity Tetiana Pavlovska, Ruslan Gr. Redkin, Victoria V. Lipson et al. · Molecular Diversity 29 Sep 2015 347
2 Antivirulence as a new antibacterial approach for chemotherapy Sonia Escaich · Current Opinion in Chemical Biology Review 18 Jul 2008 178
3 Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage Erwann Le Rouzic et al. · Retrovirology Open access 21 Nov 2013 131
4 Structure of the Escherichia coli Heptosyltransferase WaaC: Binary Complexes with ADP AND ADP-2-deoxy-2-fluoro Heptose Sylvestre Grizot, Michèle Salem, Vanida Vongsouthi et al. · Journal of Molecular Biology Aug 2006 98
5 Discovery of new Gram-negative antivirulence drugs: Structure and properties of novel E. coli WaaC inhibitors François Moreau, Nicolas Desroy, Jean-Marie Genevard et al. · Bioorganic & Medicinal Chemistry Letters 6 Jun 2008 90
6 Crystal Structures of Novel Non-peptidic, Non-zinc Chelating Inhibitors Bound to MMP-12 Renaud Morales, Sophie Perrier, Jean-Michel Florent et al. · Journal of Molecular Biology 2 Jul 2004 86
7 The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound Sonia Escaich, Laure Prouvensier, Marc Saccomani et al. · Antimicrobial Agents and Chemotherapy Open access 9 Aug 2011 79
8 Towards Gram-negative antivirulence drugs: New inhibitors of HldE kinase Nicolas Desroy, François Moreau, Sophia Briet et al. · Bioorganic & Medicinal Chemistry Open access 25 Dec 2008 72
9 Identification of Candidates for a Subunit Vaccine against Extraintestinal Pathogenic Escherichia coli Lionel Durant, Arnaud Métais, Coralie Soulama-Mouze et al. · Infection and Immunity Open access 5 Dec 2006 64
10 From Triclosan toward the Clinic: Discovery of Nonbiocidal, Potent FabI Inhibitors for the Treatment of Resistant Bacteria Vincent Gerusz et al. · Journal of Medicinal Chemistry Open access 23 Oct 2012 57
11 Structural Basis for E. coli Penicillin Binding Protein (PBP) 2 Inhibition, a Platform for Drug Design Nicolas Lévy, Jean‐Michel Bruneau, Erwann Le Rouzic et al. · Journal of Medicinal Chemistry Open access 17 Apr 2019 50
12 RegR, a Global LacI/GalR Family Regulator, Modulates Virulence and Competence in Streptococcus pneumoniae Sabine Chapuy‐Regaud, Abiodun David Ogunniyi, Nicole Diallo et al. · Infection and Immunity Open access 18 Apr 2003 48
13 Systematic Synthesis of Inhibitors of the Two First Enzymes of the Bacterial Heptose Biosynthetic Pathway: Towards Antivirulence Molecules Targeting Lipopolysaccharide Biosynthesis Maxime Durka, Abdellatif Tikad, Régis Périon et al. · Chemistry - A European Journal 26 Aug 2011 46
14 Stereoselective Glycal Fluorophosphorylation: Synthesis of ADP‐2‐fluoroheptose, an Inhibitor of the LPS Biosynthesis Hirofumi Dohi, Régis Périon, Maxime Durka et al. · Chemistry - A European Journal 2 Oct 2008 46
15 Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration Damien Bonnard, Erwann Le Rouzic, Sylvia Eiler et al. · Journal of Biological Chemistry Open access 5 Mar 2018 42
16 Structure–Activity Relationship Analysis of the Peptide Deformylase Inhibitor 5‐Bromo‐1H‐indole‐3‐acetohydroxamic Acid Sylvain Petit, Yann Duroc, Valéry Larue et al. · ChemMedChem 3 Dec 2008 42
17 Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import Alexandra Cribier, Emmanuel Ségéral, Olivier Delelis et al. · Retrovirology Open access Dec 2011 38
18 Synthesis and Biological Activity of New Thiopyrano[2,3-d]thiazoles Containing a Naphthoquinone Moiety Dmytro V. Atamanyuk · Scientia Pharmaceutica Open access 2013 33
19 Novel HldE-K Inhibitors Leading to Attenuated Gram Negative Bacterial Virulence Nicolas Desroy, Alexis Denis, Chrystelle Oliveira et al. · Journal of Medicinal Chemistry 14 Feb 2013 32
20 Recent Advances in the Inhibition of Bacterial Fatty Acid Biosynthesis Vincent Gerusz · Annual reports in medicinal chemistry Book chapter 2010 29
21 The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity Céline Amadori et al. · Retrovirology Open access 9 Nov 2017 24
22 The Allosteric HIV-1 Integrase Inhibitor BI-D Affects Virion Maturation but Does Not Influence Packaging of a Functional RNA Genome Nikki van Bel, Yme van der Velden, Damien Bonnard et al. · PLoS ONE Open access 29 Jul 2014 23
23 Structural–Functional Studies of Burkholderia cenocepacia d -Glycero-β- d -manno-heptose 7-Phosphate Kinase (HldA) and Characterization of Inhibitors with Antibiotic Adjuvant and Antivirulence Properties Ting-Wai Lee, Theodore B. Verhey, Pavel Antiperovitch et al. · Journal of Medicinal Chemistry Open access 20 Dec 2012 18
24 AT2 Receptor‐Interacting Proteins ATIPs in the Brain Sylvie Rodrigues-Ferreira, Erwann Le Rouzic, Traci L. Pawlowski et al. · International Journal of Hypertension Open access 2013 12
25 Towards Gram-positive antivirulence drugs: New inhibitors of Streptococcus agalactiae Stk1 Mayalen Oxoby, François Moreau, Lionel Durant et al. · Bioorganic & Medicinal Chemistry Letters 8 May 2010 5
26 Vectorization Efforts To Increase Gram-Negative Intracellular Drug Concentration: A Case Study on HldE-K Inhibitors Dmytro V. Atamanyuk, Fabien Faivre, Mayalen Oxoby et al. · Journal of Medicinal Chemistry 27 Feb 2013 5
27 Synthesis of 1,5-Anhydro-d-glycero-d-gluco-heptitol Derivatives as Potential Inhibitors of Bacterial Heptose Biosynthetic Pathways Paul Kosma, Markus K. Blaukopf, Dmytro V. Atamanyuk et al. · Synthesis 8 Nov 2017 4
28 Potentiating Activity of GmhA Inhibitors on Gram-Negative Bacteria François Moreau, Dmytro V. Atamanyuk, Markus K. Blaukopf et al. · Journal of Medicinal Chemistry Open access 10 Apr 2024 2
29 Synthesis of new 1-[2-Azido-2-(2,4-dichlorophenyl)ethyl]-1H/-imidazoles andin vitroevaluation of their antifungal activity Francis Chevreuil, Anne Landreau, Denis Séraphin et al. · Journal of Enzyme Inhibition and Medicinal Chemistry Open access 2008 2
30 New chimeric peptide regulating insulin-like growth factor 1 regenerative effect for therapy in early stage osteoarthritis Rossella Paolini, C. Vêtu · Osteoarthritis and Cartilage Open access Apr 2017 1
31 ChemInform Abstract: Discovery of New Gram‐Negative Antivirulence Drugs: Structure and Properties of Novel E.coli WaaC Inhibitors. Alexis Denis, et al. et al. · ChemInform 27 Oct 2008 0
32 New Chimeric peptides regulating IGF-1 show significant therapeutic effect on anterior cruciate ligament transection rabbit model of osteoarthritis Rossella Paolini, Rodrick Montjean, C. Vêtu · Osteoarthritis and Cartilage Open access Apr 2018 0
33 Cover Picture: Structure–Activity Relationship Analysis of the Peptide Deformylase Inhibitor 5‐Bromo‐1H‐indole‐3‐acetohydroxamic Acid (ChemMedChem 2/2009) Sylvain Petit, Yann Duroc, Valéry Larue et al. · ChemMedChem Open access 5 Feb 2009 0
34 Cover Picture: Stereoselective Glycal Fluorophosphorylation: Synthesis of ADP‐2‐fluoroheptose, an Inhibitor of the LPS Biosynthesis (Chem. Eur. J. 31/2008) Hirofumi Dohi, Régis Périon, Maxime Durka et al. · Chemistry - A European Journal Open access 21 Oct 2008 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.